Definiens and Cernostics partner to develop multiplexed cancer diagnostic tests
Cernostics Inc., a biotechnology firm specializing in advanced cancer diagnostics, and Geisinger Health System, a $2.1 billion integrated health services organization, today announced a partnership in personalized healthcare. They will focus on devel...
Read more
